Agape ATP's $24 Billion Breakthrough! In a market landscape clouded by macroeconomic uncertainty and weakening sentiment, Agape ATP Corporation (NASDAQ: ATPC) has emerged as a countercyclical outlier with its recent announcement of two landmark Sales and Purchase Agreements (SPAs) worth approximately USD 24 billion. Signed with Swiss One Oil & Gas AG, these agreements mark a bold step forward for ATPC, setting the stage for an ambitious entry into the refined fuels distribution market on a global scale.
The SPAs follow a successful Initial Corporate Purchase Order (ICPO) completed in February 2025, which served as a proving ground for initial trial shipments. Under the terms of the agreements, ATPC will initially supply 200,000 metric tonnes of EN590 10PPM diesel and 2 million barrels of Jet Fuel A1 in March 2025. Following successful execution of this validation phase, the contracts are structured to scale rapidly to weekly deliveries of 500,000 metric tonnes of diesel and 2 million barrels of Jet Fuel A1 — an exponential increase that underscores the strategic ambition of both parties.
All deliveries will be conducted using Free on Board (FOB) procedures at major international ports, with product quality certified by SGS or equivalent agencies in accordance with ASTM/IP standards. This not only enhances transparency and credibility but also signals ATPC's commitment to international compliance and operational rigour.
What makes this deal truly transformative is the sheer scale of the undertaking. If executed to full potential, weekly deliveries of 2 million barrels of jet fuel would translate into an annual supply of roughly 104 million barrels — equivalent to around 2% of total annual U.S. jet fuel consumption. Such volume would position ATPC as a serious contender within the global energy trade ecosystem, shifting its profile from a relatively obscure player to a recognisable force in refined fuel logistics and supply.
The structural staging of the agreement — trial, validation, then full-scale execution — reveals a commercially astute strategy. It reduces upfront risk and capital exposure while providing room for operational ramp-up and systems optimisation. However, the magnitude of the weekly delivery requirements suggests that ATPC must urgently enhance its logistical capabilities, secure dependable supply sources, and establish robust quality assurance and compliance frameworks.
From a financial standpoint, the implications are staggering. The USD 24 billion value of the agreements stands in stark contrast to ATPC's current market capitalisation of just USD 5.17 million — a disconnect representing a multiple of over 4,600 times. While such disparity is not uncommon in early-stage high-growth stories, it highlights the importance of scrutinising the company’s readiness to scale operationally and financially.
Under FOB terms, ATPC will bear the cost of acquiring and transporting the fuel to the port of loading, thereby requiring significant working capital. Timely financing and cash flow management will be paramount, especially as delivery volume scales. Questions surrounding margin structure, procurement reliability, and commodity price hedging strategies will need to be addressed to fully appreciate the risk-return profile of this venture.
Yet, amid broader market softness and investor caution, ATPC’s bold strategic execution stands out. If the company successfully navigates the complex logistics, financial demands, and operational scale-up, this agreement has the potential to redefine its financial trajectory and long-term shareholder value.
In an era where execution is everything, Agape ATP’s audacious move could very well prove prescient. Investors will be watching closely — not just for signs of progress, but for proof of delivery.
Article inspired by Stock Titan.
ATPC trade ideas
Agape ATP Corporation (ATPC) Technical Analysis | 31 March 2025Agape ATP Corporation (ATPC) has demonstrated a significant breakout above a key resistance level, with the current price trading at $1.18, reflecting an increase of +0.85% on the day. The bullish move is backed by an increase in trading volume from the previous trading day, which signals renewed investor interest and growing confidence in the stock’s upward trajectory.
This breakout marks a shift in sentiment, indicating the potential for a sustained rally as the price decisively cleared its previous consolidation range.
The price action has remained consistently above the Exponential Moving Average (EMA) slope cross indicator, with the dynamic support now situated between $1.12 and $1.17. The bullish crossover of the EMA signals confirms a strengthening uptrend, as the widening of the EMA cloud suggests that buying pressure is increasing. Historically, such a pattern indicates that the breakout is not merely a short-term spike but a shift toward higher price levels, paving the way for sustained gains.
The EMA zone is expected to act as a buffer against any minor retracement, maintaining bullish momentum.
Adding to the bullish outlook is the Relative Strength Index (RSI) Divergence Indicator (14, close), which currently stands at 81.14, suggesting that the stock has entered overbought territory. While an overbought condition often raises concerns of a potential pullback, in the context of a strong breakout, it typically serves as a confirmation of the stock’s strength.
Stocks that experience such momentum tend to remain in overbought territory for extended periods before any meaningful consolidation occurs. The RSI divergence, which previously indicated bearish pressure, has been invalidated by the recent surge, giving further credence to the current bullish momentum.
The breakout above $1.18 is significant as it marks the upper limit of a prolonged consolidation phase where buyers have consistently absorbed selling pressure. Throughout this consolidation, the emergence of multiple “Long” buy signals, combined with a noticeable reduction in “Short” signals, indicated that accumulation was underway. The recent breakout confirms that buyers have taken control, and the subsiding of selling pressure further strengthens the bullish case. The consistency of these buy signals, coupled with increased volume, suggests that the breakout is not merely speculative but supported by strong underlying demand.
Overall, the technical setup suggests that ATPC is well-positioned for further upside. The combination of a decisive breakout, increasing volume, and sustained bullish signals points to the likelihood of continued gains. With momentum firmly in favour of the bulls and the stock showing resilience above key levels, the outlook remains positive. Investors should monitor the price action closely for confirmation of continued strength, with a focus on maintaining support above $1.12 while aiming for potential targets of $1.25 to $1.30 in the near term. If momentum persists, a further extension toward $1.40 could be possible, supported by the bullish market sentiment surrounding the stock.
ATPC’s Selling Pressure Eases an Shows Signs of AccumulationAgape ATP Corporation (NASDAQ: ATPC) has seen a noticeable shift in its trading dynamics in recent weeks, as technical indicators point to a subsiding of selling pressure and early signals of possible fund accumulation. Following a volatile start to 2025, the stock is now displaying signs of base-building that could pave the way for a potential recovery.
From Capitulation to Consolidation
The counter experienced sharp declines earlier in the year, with a significant drop towards the $0.90 level in early March – a move that bore hallmarks of panic selling or capitulation. However, since hitting this low, the stock has stabilised and is now trading steadily within the $1.04–1.05 range. This stabilisation, coupled with narrower daily candle ranges and subdued volume, suggests that the worst of the selling pressure may now be behind.
Adding to this view are recent candlesticks with extended lower wicks – a classic signal of buying interest emerging on dips. The price action appears to be forming a technical base, potentially supported by buyers absorbing selling flows at lower levels.
Signs of Institutional Interest
While the price remains below its longer-term moving averages (MA120 at $1.38 and MA250 at $2.69), the flattening of shorter-term moving averages – MA5 ($1.034), MA10 ($1.031), and MA20 ($1.045) – is worth noting. These moving averages are now converging, hinting at a possible shift in momentum from bearish to neutral, or even bullish, if confirmed by subsequent price action.
A spike in volume observed in late February also lends credence to the idea of accumulation. Unlike speculative volume surges that tend to be followed by erratic moves, the stock’s ability to retain its gains and enter into consolidation territory suggests that stronger hands may be quietly positioning themselves.
The relatively modest turnover reading of 0.007 also supports this theory, indicating that accumulation may be occurring under the radar, without triggering undue volatility – a method often employed by institutional participants.
Key Levels to Monitor
The $1.00 level has emerged as a psychological and technical support zone, holding firm despite previous attempts to break lower. On the upside, traders and investors alike should watch for a clean break above the MA20 at $1.045, which could invite further momentum. A decisive move beyond the $1.10–1.15 resistance range, ideally accompanied by a pick-up in volume, would strengthen the bullish outlook and likely confirm fund-backed buying interest.
Conclusion
ATPC is currently at an interesting technical juncture. With selling pressure appearing to ease and signs of quiet accumulation beginning to surface, the stock may be transitioning from a downtrend into a potential recovery phase. Investors looking for early positioning may wish to monitor upcoming volume and price movements closely, particularly as the stock tests its short-term resistance levels.
Quick Technical Take on Agape ATP Corporation (ATPC)Let’s break down the 1-hour chart for Agape ATP Corporation (ATPC) as of March 20, 2025. The stock’s sitting at $1.02, down about 1%, and it’s been a wild ride lately.
The price spiked to $3.00 in late January before crashing hard. Since then, it’s been hanging around the $1.00 mark, which has been a solid support; buyers keep stepping in here, like clockwork, especially in early March.
The Bollinger Bands show the price dipping below the lower band in mid-February, hinting at an oversold bounce, and now it’s consolidating near that $1.00 level. We’ve got a recent "Sell" signal at $1.06, so there’s some short-term bearish pressure.
The SmartMCDX indicator below the chart is flashing mixed signals: green for bullish, red for bearish. Lately, it’s leaning red, suggesting the bears might have the upper hand for now. Volume’s pretty quiet, which means no big players are jumping in yet, so we might just keep drifting near $1.00.
What to Watch : If the price holds above $1.00, we could see a push toward $1.06 or even $1.20. But if it breaks below $1.00, things could get ugly, maybe dropping to $0.90. For now, I’d sit tight and see which way the wind blows; $1.00 is the key.
The Rapid Growing Malaysia Health Care SectorMalaysia’s healthcare landscape is entering a transformative phase, underpinned by a robust allocation of RM45.3 billion in the 2025 national budget—a 10% increase compared to 2024. This commitment, the second-largest budget allocation after education, underscores the government’s focus on addressing rising healthcare demands, including an ageing population, chronic diseases, and urban-rural healthcare gaps.
The government’s strategic initiatives, including RM1.3 billion for hospital upgrades and RM300 million for dilapidated clinics in rural areas, highlight a push towards more efficient healthcare delivery. Fitch Solutions’ BMI predicts that Malaysia's healthcare expenditure will grow at an impressive compound annual growth rate (CAGR) of 8.7% from 2023 to 2028, outpacing previous estimates. This growth will be fuelled by increased demand for both public and private healthcare services, bolstered by initiatives such as outsourcing public patient care to 91 private hospitals and the gradual rollback of subsidies for higher-income individuals. The shift in subsidies is expected to drive affluent patients towards private healthcare, expanding opportunities for private healthcare providers.
Private healthcare companies, especially those involved in preventive care and supplements, stand to benefit significantly from these trends. One notable player is Nasdaq-listed Agape ATP Corporation (ATPC), a leading healthcare supplement company in Malaysia. With Malaysia’s emphasis on chronic disease prevention and healthier lifestyles, Agape ATP is well-positioned to meet the rising demand for wellness products. The company’s established reputation and product range make it an attractive choice as the nation prioritises self-sufficiency in medical products and preventive healthcare.
Moreover, the government’s New Industrial Master Plan 2030, aimed at strengthening domestic production of medical products, offers additional prospects for growth. By focusing on advanced diagnostic tools and in-vitro diagnostics, Malaysia is setting the stage for a more globally competitive healthcare ecosystem. As healthcare spending increases and demand for quality services rises, companies like Agape ATP are likely to see enhanced opportunities to expand and thrive. For investors, Malaysia’s growing healthcare sector and its well-aligned private players present a compelling case for long-term value.
In-Depth Technical Review on Agape ATP Corporate (NASDAQ: ATPC)The following is the transcript of the ATPC analysis video.
Agape ATP Corporation’s (NASDAQ: ATPC) daily chart reflects a prolonged period of consolidation, following sharp price volatility earlier in the year.
Notably, the share price has stabilised around the $1.40 to $1.50 range for the past weeks, suggesting that a base may be forming after its earlier decline.
From a technical perspective, the MACD indicator provides valuable insight. The MACD line (represented in blue) has remained close to the signal line (orange) with minimal divergence, indicating a lack of decisive momentum for now.
Additionally, histogram bars oscillate around the zero line, suggesting that buying and selling pressures are relatively balanced.
Turning to the Relative Strength Index (RSI), the indicator is currently hovering around 46.7, which places it in the neutral zone. This suggests that the stock is neither overbought nor oversold, aligning with the lack of a clear directional trend.
A move above 50 could signal increasing bullish momentum, while a drop below 40 would reflect growing selling pressure.
Zooming out, the share price has been in a downtrend since mid-year but appears to have found a floor near the $1.40 level. While short-term volatility has subsided, the lack of volume and weak momentum indicators signal that traders are awaiting a catalyst to trigger the next significant price movement.
In summary, ATPC’s technical indicators – the flat MACD and neutral RSI – suggest the stock is currently in a consolidation phase. Moving forward, traders should monitor any significant breakout above resistance above USD 1.50 level for a trend reversion confirmation.
HSBC: Opportunities Arises in Southeast Asia’s Healthcare SectorSoutheast Asia's healthcare sector is experiencing a seismic shift, driven by rising affluence, an aging population, and rapid advancements in medical technology. HSBC’s latest outlook highlights the immense growth potential in the region’s healthcare market, underpinned by increasing demand for better medical infrastructure, innovative treatments, and wellness solutions.
With Southeast Asia’s population exceeding 685 million, the region is facing a dramatic demographic transition. By 2050, the proportion of people aged 60 and above is expected to double to 22.2%, creating significant demand for healthcare services, particularly in addressing aging-related conditions like dementia, mental health, and mobility challenges.
While countries like Singapore and Malaysia have relatively high physician-to-population ratios, nations such as Indonesia and the Philippines lag, putting additional strain on already stretched systems.
This demographic shift is compounded by rising wealth, with GDP per capita on a purchasing-power-parity basis projected to reach USD23,260 by 2029. Increased affluence is driving higher healthcare expenditure, with Malaysia and Singapore, for instance, significantly boosting their healthcare budgets in 2024. Across ASEAN, total healthcare expenditure rose by 42% from 2016 to USD156.3 billion in 2021, a trend expected to continue as governments and private entities ramp up investments in the sector.
The region is undergoing a rapid build-out of medical infrastructure, from hospitals and clinics to senior care facilities. Additionally, medical tourism continues to flourish, with Malaysia, Thailand, and Singapore emerging as key destinations. By 2029, the industry is expected to more than double, surpassing USD100 billion annually.
Southeast Asia is grappling with a surge in non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, and cancer. For example, the number of people living with diabetes in Indonesia tripled over the last two decades and is expected to grow by another 47% by 2045. This has spurred demand for innovative treatments, advanced medical equipment, and research collaborations to address these escalating health challenges.
Source: HSBC's Report
While many companies are vying for a share of the expanding Southeast Asian healthcare market, one emerging player, NASDAQ-listed Agape ATP Corporation (ATPC), recently made headlines. The company announced the signing of three Memorandums of Understanding (MOUs) with prominent healthcare institutions in Indonesia.
These agreements aim to advance medical research, introduce innovative treatment strategies, and bolster training programs targeting respiratory diseases like tuberculosis (TB) and chronic obstructive pulmonary disease (COPD). This strategic move positions ATPC as a promising beneficiary of the region’s healthcare transformation and underscores the opportunities for businesses willing to innovate and invest in the sector.
As Southeast Asia's healthcare landscape continues to evolve, companies like ATPC exemplify how strategic initiatives can align with the region’s growing needs, paving the way for sustainable growth in one of the world's fastest-changing markets.
Agape ATP Corporation - Is a Trend Reversal on the Horizon?If you’ve been keeping an eye on Agape ATP Corporation (NASDAQ: ATPC), you’d notice that the stock has been on a downtrend for quite some time.
However, there are some subtle but interesting signs popping up on the chart that suggest things might be taking a turn for the better. Let’s break it down in simple terms.
For weeks now, the price has been holding steady around the $1.50 mark.
This is a big deal because it shows that the sellers might be running out of steam. It’s like a tug-of-war between buyers and sellers, and right now, the buyers seem to be putting up a good fight.
One of the first things traders look for in a potential trend reversal is volume, and it’s starting to show some life here. Over the past few weeks, we’ve seen turnover starting to tick up.
Why is this important?
Because volume tells you where the action is. If more people are trading the stock, it often means something is brewing.
Alright, let’s not get too technical here, but moving averages (MAs) are basically the average prices over a set period.
ATPC’s shorter-term MA10 (10-day moving average) is beginning to flatten out. If the stock price can break above this level, it’s a strong signal that a new uptrend might be starting.
Think of $1.50 as a floor. If the stock doesn’t drop below this level and starts climbing, it’s a sign of strength. Traders often keep an eye on such levels because they can act as launching pads for upward momentum.
When you put all these signs together—stabilising price, increasing volume, flattening moving averages—it looks like the downtrend could be running out of gas. Sure, we’re not seeing fireworks yet, but the early signals are there.
What Should You Do?
If you’re thinking of jumping in, here’s the plan:
• Watch the RM1.50 level like a hawk. If the price stays above it, that’s a good sign.
• Look for more volume in the coming weeks. If it keeps picking up, the trend reversal could be real.
• Keep an eye on the short-term MA10. A break above this line might be the green light you’re waiting for.
As always, do your homework and manage your risk. No one knows for sure what will happen, but the signs are looking promising for ATPC.
If a reversal is indeed underway, it could be a chance to catch the stock on the ground floor of a potential new uptrend. Stay sharp!
Why This Health and Energy Company Could Be a Good InvestmentThis company (NASDAQ: ATPC) is based in Malaysia and focuses on health and energy solutions. Even though its stock prices have had ups and downs, it offers some promising reasons why you might want to consider investing.
1. Wide Range of Health Products
The company provides various health-related items, such as supplements that improve cell health, help detoxify the body, support better blood flow, and reduce aging effects. These products cover many health needs, showing that the company takes a broad approach to wellness.
2. Focus on Innovation and Partnerships
It’s not just about what they sell; the company has teamed up with others to create new solutions. For example, it recently introduced an advanced device to improve breathing, which is a timely response to health concerns around the world. This shows they’re not afraid to innovate and work with others to grow.
3. Expanding into Clean Energy
The company is also looking beyond health and moving into renewable energy. It’s working with partners to make solar energy systems more accessible in Southeast Asia. By diversifying into this booming sector, the company is setting itself up to ride the wave of global demand for sustainable solutions.
4. Staying on Track with Global Standards
The company recently met the stock exchange’s rules to stay listed, which is a sign of good management and stability. Being listed on a major exchange boosts its credibility with investors.
Why It Could Be a Smart Buy
This company’s mix of health products, clean energy efforts, and commitment to staying competitive on the global stage makes it worth considering. Of course, as with any investment, you’ll want to do your own research and weigh the risks before deciding.
Agape ATP Corporation (NASDAQ: ATPC) Q3 Results AnalysisAgape ATP Corporation (NASDAQ: ATPC) is progressing through a strategic gestation period, investing in key areas to drive long-term growth. While Q3 2024 saw a slightly higher net loss compared with Q3 2023, these numbers reflect ATPC’s commitment to building its foundation for sustainable growth.
Revenue reached $331,289 for the quarter and $962,971 for the nine months, slightly down year-over-year, as the company realigns its product offerings and marketing strategies to capture new market segments.
A significant contributor to ATPC’s current resilience is its complementary health therapies sector, which showed a revenue increase to $227,249 for the quarter and $688,415 for the year-to-date, reflecting demand for health services that align with wellness trends.
To further diversify, ATPC’s new venture in renewable energy—spearheaded by ATPC Green Energy Sdn. Bhd. (AGE)—positions the company within a high-potential sector committed to environmental sustainability.
Despite the current challenges in its network marketing segment, ATPC’s focus on refining this channel and expanding its product range indicates a proactive approach to overcoming temporary setbacks.
As ATPC completes this foundational phase, its broadening scope in wellness and green energy promises a strengthened and more versatile position in the market, setting the stage for a promising trajectory.
Technical Review - Agape ATP Corporation (ATPC) Agape ATP Corporation (ATPC) is showing promising signs of a potential upward breakout as it consolidates within a steady range, with strong support observed at $1.50. This level has consistently attracted buyers, reinforcing confidence and creating a solid foundation for a bullish move. Should the price continue to hold above this point, it indicates healthy accumulation, positioning ATPC for potential growth.
On the upside, $2.00 has emerged as the primary resistance level, but recent price action suggests a brewing momentum to break through this barrier. A successful move beyond $2.00, especially if accompanied by an increase in trading volume, would signal a breakout, opening up a pathway to $2.50. This resistance level serves as the next target, where a surge could propel the stock into a new trading range, attracting more bullish interest.
Supporting this outlook, the technical indicators add strength to the bullish case. While the MACD reflects a steady buying interest, the MCDX Plus shows signs of accumulation with increasing momentum in the green zone. This suggests that buyers are building up positions, indicating underlying strength that could fuel a significant rally once the $2.00 level is breached.
In summary, ATPC is primed for a bullish breakout, with a solid support base at $1.50 and clear resistance at $2.00. Investors should keep an eye on the volume and momentum indicators, as a sustained move above $2.00 could lead to further gains towards $2.50 and beyond.
2025 Bright Outlook for Malaysia's Renewable FutureThe Malaysian Budget 2025 has set the stage for significant growth in the renewable energy sector, particularly solar power. With a renewed commitment to transitioning towards clean energy, the government has extended several key initiatives that support the development of solar energy solutions across the country.
This includes the continuation of the Green Technology Financing Scheme (GTFS) with a substantial funding amount of RM1 billion up to the year 2026, which is intended to foster a thriving renewable energy sector in Malaysia.
Additionally, Budget 2025 allocates over RM300 million under the National Energy Transition Fund (NETR), which represents a significant increase from the RM100 million allocated previously. This boost is intended to solidify Malaysia's position as a leader in renewable energy and accelerate the country's energy landscape transformation.
The demand for solar energy continues to grow, driven by the extension of the net energy metering (NEM) program until June 2025. This extension is a critical measure to encourage clean energy adoption among residential and industrial users, further propelling the nation's shift towards renewable power sources.
The government is also providing e-rebates of up to RM70 million to promote the adoption of energy-efficient electrical equipment, which will not only reduce energy consumption but also incentivize businesses and individuals to transition to more sustainable energy solutions.
These initiatives create opportunities for various players in the solar energy field, particularly smaller companies that are well-positioned to leverage the increasing adoption of renewable technologies. For example, Agape ATP Corporation (ATPC), listed on the Nasdaq, is among the smaller players that could benefit from this positive policy environment.
Recently, Agape ATP Corporation's subsidiary, ATPC Green Energy Sdn Bhd, has teamed up with Phoenix Green Energy Sdn Bhd to accelerate the development and commercialisation of cutting-edge solar power solutions in Malaysia. This partnership focuses on developing amorphous thin-film solar panels and related technologies to support diverse applications, particularly in power production, thereby contributing to Malaysia's transition to sustainable energy.
Additionally, Agape ATP Corporation, through ATPC Green Energy, has entered into a strategic collaboration with Xiamen Photons Solar Technology Co., Ltd to develop solar photovoltaic (PV) mounting systems for Malaysia and ASEAN countries.
This collaboration aims to support the ASEAN region's efforts towards a zero-carbon energy future, further solidifying Agape ATP's role in the renewable energy sector and positioning them to make significant contributions to the regional solar market transformation.
(Transcript) NASDAQ: ATPC | Building on the Solar Energy Game Welcome to a new era of opportunity in Malaysia’s renewable energy sector. As the country accelerates its transition to clean energy, solar power stands out as a promising area of growth and investment.
For investors looking for sustainable and profitable ventures, Agape ATP Corporation (NASDAQ: ATPC) offers an exciting entry point into this booming market.
Malaysia's government is driving the adoption of renewable energy with ambitious targets: 31% of energy from renewables by 2025 and 40% by 2035.
Solar power is at the forefront of this transition. Thanks to initiatives like the Large Scale Solar (LSS) programme and the Corporate Green Power Programme (CGPP), solar energy costs have plummeted, becoming 53% cheaper than fossil fuels in recent years.
This shift opens up substantial investment opportunities, especially as demand for sustainable energy sources grows.
Malaysia is also becoming a digital hub in Southeast Asia, with data centres playing a critical role.
These facilities require stable and reliable energy, presenting a unique opportunity for solar power. As data centres continue to expand, their energy needs are aligning with the capabilities of solar energy, especially through virtual power purchase agreements (VPPA).
By integrating solar power into their energy mix, data centres can not only lower their operational costs but also meet their sustainability goals. This makes solar a crucial partner in powering the digital age.
For investors, ATPC represents a strategic opportunity to capitalise on Malaysia's solar boom.
The company’s recent expansion under the LSS4 programme has increased our renewable energy capacity, positioning them as a key player in supplying clean power to industrial clients and data centres.
ATPC’s latest solar developments includes the collaboration with Phoenix Green Energy to drive the development and commercialisation of cutting-edge solar power solutions in Malaysia and expansion into Sabah’s solar farming sector.
This collaboration focuses on advancing a diverse portfolio of solar products, including amorphous thin-film solar panels, which are designed to support various applications, particularly in power production.
As Malaysia pushes forward with its energy transition, the demand for solar solutions will continue to grow. ATPC’s recent projects are already generating returns, with the potential for significant long-term growth as more data centres and industrial clients opt for renewable energy sources.
Now is a great timing to look into ATPC as a long-term yet sustainable investment.
Agape ATP - Synergising Innovation Across Business PillarsATPC Unveils Its Multifaceted Business Pillars to Drive Global Wellness and Sustainability
KUALA LUMPUR, MALAYSIA, 10 OCTOBER 2024 – NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to present its multifaceted business pillars, each driven by a shared vision to make the world a better place. With a strong commitment to sustainability, health, and enhancing quality of life, ATPC has strategically developed six (6) core pillars that work in synergy to address the world’s most pressing challenges, from energy conservation to advanced medical care.
ATPC’s DSY Wellness division focuses on Nutraceuticals and Nutritional Medicine, offering scientifically backed products that promote overall health and wellness. By addressing nutrition from a medical perspective, DSY Wellness aims to empower individuals to prevent and manage health issues through high-quality, natural supplements and solutions.
On the wellness front, Agape Superior Living (“ASL”) leads the way with breakthrough products like ATP2, a cutting-edge anti-ageing supplement that represents a new frontier in the wellness industry. ASL is dedicated to advancing the anti-ageing market, focusing on improving longevity and enhancing vitality. Through ASL, ATPC aims to revolutionise personal well-being, helping people live healthier and longer lives, in Malaysia and throughout the ASEAN region. Various partners are involved in different countries to offer ATP2.
ATPC Green Energy (“AGE”) spearheads ATPC's efforts in the energy sector, with initiatives aiming to provide sustainable energy solutions, reduce environmental impact, and contribute to Malaysia's clean energy transition. Through B&H Intech Solutions, now ATPC Green Energy Sdn. Bhd., realizing energy saving solutions are on the horizon via contract-talks with GLCs (government linked companies); and, with Xiamen Photons Solar Technology Co., Ltd and value chain partner, Fujian Minfa Aluminium Co., Ltd., a Shenzhen Stock Exchange-listed company, installation of photovoltaic systems for Malaysia and ASEAN countries is attainable. With a focus on innovation, AGE’s solar and energy-saving projects are laying the foundation for a greener, more energy-efficient future, making significant strides toward global sustainability. Currently, projects in Selangor and Sabah are developing with fervor and anticipation.
Cedar ATPC brings innovative healthcare solutions through Myofascial Release Therapy and Pain Relief Therapy, providing effective, non-invasive treatments that improve physical well-being. These therapies and products are designed to relieve pain and enhance mobility, offering individuals a better quality of life and empowering them to take control of their health naturally.
In the medical device sector, ATPC’s collaboration with FORMEDIC Technologies Sdn. Bhd. marks a significant step forward in respiratory care. The LEGA device, a pioneering electronic chest percussion device, has been developed to assist patients suffering from chronic obstructive pulmonary diseases (“COPD”) and other respiratory conditions. This cutting-edge medical device exemplifies ATPC’s commitment to advancing healthcare and improving patient outcomes through innovative solutions.
Lastly, recognising the importance of care in the later stages of life, the Senior Living business pillar is dedicated to fostering vibrant Senior Communities that promote healthy and fulfilling lives for the elderly. ATPC’s approach to senior living is focused on creating safe, supportive environments where seniors can thrive socially, physically, and emotionally, enhancing their overall well-being in their golden years.
Prof Dato’ Sri Dr How Kok Choong, the Founder and Global Group CEO of ATPC expressed the company’s mission, “At ATPC, we are committed to leveraging our expertise across multiple sectors to create synergies that not only drive business growth but also contribute to making the world a better place. From sustainable energy projects to life-enhancing medical devices and wellness products, each of our business pillars plays a vital role in shaping a future where health, well-being, and sustainability are within reach for all.”
With a diversified portfolio spanning renewable energy, wellness products, healthcare solutions, and senior care, ATPC stands as a forward-thinking company dedicated to positively impacting lives and creating a sustainable future. Through its integrated approach, ATPC is poised to lead the way in transforming how people live, age, and experience healthcare, all while promoting a greener, healthier planet.
NASDAQ: ATPC | Technical Review 07/10/2024Support: $1.800
Resistance: $2.000
Agape ATP Corporation (NASDAQ: ATPC) is showing significant support and resilient in the $1.800 level for the past trading weeks. This is likely to be supported by (i) compliance of the company's share price to Nasdaq, (ii) strong exposure in renewable energy sector and (iii) launching of significant revenue generator, ATP2.
ATPC and FORMEDIC Technologies Announce Strategic Collaboration Innovative Collaboration Brings Advanced Respiratory Solutions to a Global Market
KUALA LUMPUR, 1 OCTOBER 2024 – NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to announce a strategic collaboration with FORMEDIC Technologies Sdn. Bhd. (“FORMEDIC Technologies”) to introduce LEGA, an electronic chest percussion device for respiratory care. This partnership marks a major advancement in respiratory health, as the two companies combine their strengths to address the growing demand for advanced respiratory solutions.
LEGA, FORMEDIC’s flagship product, assists patients with chronic obstructive pulmonary diseases (“COPD”), pneumonia, bronchiectasis, and other lung-related conditions by providing critical support for airway clearance and secretion management. LEGA helps to manage secretion drainage and airway clearance, offering much-needed relief to patients both adults and children, facing respiratory difficulties in both hospital and home care settings. This device has already gained significant traction in the medical field, with close to 2,000 units used in major hospitals and rehabilitation centres in Malaysia and globally.
For ATPC, this collaboration brings opportunities in the fast-growing respiratory care market, estimated to reach USD 25.95 billion in 2024, with a strong growth trajectory, estimating it to hit USD 49.84 billion by 2031 . As respiratory diseases continue to rise globally, this partnership positions ATPC to capitalise on the increasing demand for advanced respiratory solutions, as well as diversifying its wellness portfolio with a proven medical device.
Prof Dato' Sri Dr How Kok Choong, the Founder and Global Group CEO of ATPC, said, "The partnership allows ATPC to leverage FORMEDIC’s expertise in healthcare technology and clinical applications and research and development capabilities, aligning with ATPC’s long-term vision of building a holistic wellness ecosystem that encompasses both preventive and curative solutions.
This is an opportunity for us to address a critical global health need. With LEGA, we are expanding our operations into healthcare technology, an area with immense growth potential. We look forward to continue delivering value through innovation and strategic diversification, and at the same time, accelerate ATPC’s growth and market reach, enhancing shareholder value.”
Ng Zim Guan, Director of FORMEDIC Technologies, added, "LEGA is the culmination of years of research and clinical trials, and our partnership with ATPC allows us to reach more patients globally. We aim to redefine respiratory care with cutting-edge solutions and LEGA’s non-invasive, electronic chest percussion technology has already proven to be a vital tool in improving respiratory health. Partnering with ATPC allows us to further scale this technology and reach more patients in need."
In addition to improving lung health, the collaboration will focus on continuous R&D efforts to explore innovations and develop solutions to improve patient outcomes. ATPC and FORMEDIC will jointly develop marketing strategies to position LEGA as the leading respiratory care solution, ensuring greater accessibility to hospitals, rehabilitation centres, and home users globally.
NASDAQ: ATPC | Technical Review 24/09/30Agape ATP Corporation (NASDAQ: ATPC) , a specialist in renewable energy and wellness products, has demonstrated strong support around the $1.90 level following its compliance with Nasdaq listing requirements.
Recent accumulation activity over the past two weeks suggests the potential for a trend reversal, with downside risks mitigated by key moving average (MA) levels providing support. In the short term, we anticipate a possible challenge of the $2.00 level, while our mid-term target remains at $2.89, supported by current technical indicators and momentum.
Agape ATP Launches ATP2, the Future of Health for Ultimate VitalNow Enhanced with 76 Essential Minerals, 20 Amino Acids, and Advanced Enzymes to Support Overall Wellness
KUALA LUMPUR, 23 SEPTEMBER 2024 – NASDAQ-listed AGAPE ATP Corporation ("ATPC"), through its subsidiary, AGAPE Superior Living Sdn. Bhd (“ASL”)., proudly unveils the enhanced version of its wellness flagship supplement, ATP2. This groundbreaking product, improved with advanced scientific developments, is designed to address key health challenges including aging, metabolism, and chronic disease management. ATP2 represents a significant advancement in nutritional science, offering a holistic approach to improving health, boosting energy, and supporting overall well-being.
At the launch, ATPC announced that the company is targeting to sell 5,000 units by the end of the year, driven by the product’s unique blend of plant-based enzymes, minerals, amino acids, and cutting-edge hydrogen acetate technology. ATPC is confident that demand will surge as consumers increasingly seek natural solutions to improve their health and vitality.
Dr. Fernando Cortizo, the President of Research and Development Team of ASL, said, "The future of nutrition is in our ability to reverse the effects of chronic diseases and aging. ATP2 is a supplement which embodies this vision, combining cutting-edge science with a powerful mix of enzymes, minerals, and amino acids. ATP2 is designed to tackle a variety of health concerns. Its unique formulation supports increased energy production by enhancing Nicotinamide Adenine Dinucleotide (“NADH+”) levels in the body.”
ATP2’s enhanced formula integrates an advanced blend of cutting-edge ingredients that include plant-based enzymes, 76 essential minerals, and 20 amino acids, all working synergistically with its core ingredient, hydrogen acetate, a unique component that has been scientifically proven to improve metabolism, reduce inflammation, and assist in reversing the effects of aging. The added ingredient works more effectively to increase cellular health, regulate key bodily functions, and support long-term vitality.
Prof Dato' Sri Dr How Kok Choong, the Founder and Global Group CEO of ATPC, said, "ATP2 plays a critical role in managing blood pressure and blood sugar levels, promoting cardiovascular health and improving gut flora. The product’s anti-aging properties come from its ability to enhance cellular repair, reduce oxidative stress, and stabilize genome function, helping users maintain a youthful, energetic state as they age.”
How added, “This product is a major milestone for ATPC. It reflects our ongoing commitment to innovation in wellness. ATP2’s comprehensive formula addresses some of the most significant health challenges today. With its ability to improve metabolism, manage chronic conditions, and support anti-aging, ATP2 stands out as a transformative solution for anyone looking to enhance their overall health."
The product is locally manufactured, in Malaysia, ensuring the highest quality control, while its formulation incorporates advanced technologies from Australia, the USA, Europe, and Japan. By bringing production closer to home, ATPC can ensure a steady supply of ATP2 to meet consumer demand while maintaining superior quality standards.
As part of ATPC’s mission to align with the UN Sustainable Development Goals (“UNSDG”), particularly in health and well-being, ATP2 is positioned to make a lasting impact on the wellness market. By offering a scientifically backed solution that addresses common health concerns, ATPC reaffirms its role as a leader in sustainable, innovative wellness solutions.
Technical Review – ATP Corporation Corp, 20th September 2024Following the compliance of ATP Corporation Corp (NASDAQ: ATPC) on NASDAQ requirements, the share price had seen strong upside, followed by a profit taking exercise. However, judging with the lower traded volume from yesterday, ATPC is likely to enter a small consolidation phase around $1.900 to $2.000 level. We see this as a fantastic opportunity for investors who wants to accumulate or build position at the current level.
The RSI inverted indicator, as shown at the bottom, shows a neutral momentum at the moment for ATPC.
Benzinga: Why Is Agape ATP Stock Jumping Today?Zinger Key Points
Agape ATP’s stock jumps after partnering with Xiamen Photons Solar to develop solar PV systems in ASEAN countries.
The strategic collaboration aims to address grid stability and power supply issues while advancing Sabah's transition to clean energy.
Agape ATP Corporation ATPC shares are trading higher after the company announced it entered into a strategic collaboration with Xiamen Photons Solar Technology, focusing on developing solar photovoltaic mounting systems for Malaysia and ASEAN countries.
The company’s subsidiary, ATPC Green Energy, has formed a strategic collaboration with Xiamen Photons Solar Technology, a value chain partner of Fujian Minfa Aluminium Co., which is listed on the Shenzhen Stock Exchange.
The agreement was signed at Photons Solar’s headquarters in Xiamen, China.
This partnership is timely as ASEAN nations enhance their commitment to a zero-carbon energy future. Regional governments are actively implementing policies to promote renewable energy development and carbon neutrality.
The collaboration between Photons Solar and ATPC Green Energy aims to accelerate these initiatives and drive the transformation of the ASEAN solar market.
How Kok Choong, founder and global group CEO of ATPC, indicated that the collaboration with Photons Solar represents a significant advancement in their efforts to develop solar PV farms in Sabah.
The partnership is expected to tackle key challenges like grid stability and power supply issues, supporting Sabah’s transition to clean and reliable energy.
“This partnership allows us to leverage local insights and advanced technologies, further supporting our commitment to advancing renewable energy goals across the region,” the CEO added.
ATPC Partners with Photons Solar to Advance Solar PV SystemJoint Initiative to Boost Renewable Energy Adoption and Support Carbon Neutrality in the Region
KUALA LUMPUR, 13SEPTEMBER 2024 – NASDAQ-listed AGAPE ATP Corporation ("ATPC"), through its subsidiary, ATPC Green Energy Sdn. Bhd. (“ATPC Green Energy”) has entered into a strategic collaboration with Xiamen Photons Solar Technology Co., Ltd (“Photons Solar”), a value chain partner of a Shenzhen Stock Exchange-listed Fujian Minfa Aluminium Co., Ltd (“Fujian Minfa Aluminium”). This collaboration focuses on developing solar photovoltaic (PV) mounting systems for Malaysia and ASEAN countries. The agreement was signed at Photons Solar’s headquarters in Xiamen, China.
This partnership comes at a pivotal time as ASEAN countries intensify their efforts toward a zero-carbon energy future. Governments in the region have been implementing various policies to encourage the development and use of renewable energy, with a strong focus on achieving carbon neutrality. The collaboration between Photons Solar and ATPC Green Energy, both leaders in renewable energy innovation, is designed to accelerate these efforts and drive the transformation of the ASEAN solar market.
Prof Dato’ Sri Dr How Kok Choong, the Founder and Global Group CEO of ATPC said, “This partnership with Photons Solar is a strategic step forward for us as we continue to develop solar PV farms in Sabah. Our collaboration aims to address critical issues such as grid stability and power supply challenges, ultimately supporting Sabah’s shift to a clean, affordable, and reliable energy source. By aligning our efforts with a partner that shares our vision, we are well-positioned to make a significant impact on the renewable energy landscape in the region.”
“We believe that sharing technological expertise is the key to driving innovation and fostering collaboration. By working with Photons Solar, we are combining our strengths to create versatile and flexible solar solutions that cater to the diverse needs of the ASEAN market. This partnership allows us to leverage local insights and advanced technologies, further supporting our commitment to advancing renewable energy goals across the region,” How added.
Photons Solar, renowned for its extensive experience in solar PV mounting systems with over 5 gigawatts (GW) in cumulative shipments and a 960,000 square meter manufacturing facility owned by Fujian Minfa Aluminium, brings a wealth of knowledge and advanced technology to this collaboration. The company is committed to providing high-quality, efficient, and customized solar mounting solutions that cater to various customer requirements.
Mr. Paul Cao, Chief Executive Officer at Photons Solar, said, "We are pleased to partner with ATPC Green Energy, given their solid presence and experience in the ASEAN region. Collaborating with a company that understands the local market dynamics allows us to work more effectively towards our shared goals in promoting renewable energy. We look forward to this journey together.”
The projects under this collaboration will leverage Photons Solar’s state-of-the-art solar mounting systems while drawing on ATPC Green Energy’s service-oriented approach. By integrating their expertise in project management, technological innovation, product quality, and service excellence, both companies are poised to deliver efficient, reliable, and environmentally sustainable solar projects that align with the region’s energy needs.
A2Z Cust2Mate Files Patent Application for AI-PoweredTEL AVIV, ISRAEL, September 12, 2024 - A2Z Cust2Mate Solutions Corp. ("A2Z" or the "Company") (NASDAQ:AZ)(FRA - WKN:A3CSQ), a global leader in innovative technology solutions, is pleased to announce that its subsidiary Cust2Mate Ltd., a leading provider of smart shopping cart solutions, has submitted a patent application for its Shopping Cart Inventory Change Indicator System, a solution designed to address inventory shrinkage issues in retail through the application of advanced technologies, powered sophisticated proprietary artificial intelligence (AI).
In 2023, U.S. retailers suffered an estimated $142 billion in losses due to inventory shrink, 25% more than in 2022, according to a WSJ report, citing figures from investment bank William Blair.
The core of the Shopping Cart Inventory Change Indicator System is its AI-driven anomaly detection module. This module employs deep learning algorithms to monitor and analyze shopper behavior in real-time, identifying patterns that may indicate theft or other irregular activities. Complementing this, the system includes a barcode scanner for item tracking, a computer vision system with high-resolution cameras for product recognition, and a security scale that measures item weight to detect discrepancies.
A key feature of the system is its advanced change detection solution using a camera system. The high-resolution cameras are strategically positioned to capture detailed images of items placed into or removed from the shopping cart. The computer vision system processes these images to detect any changes, ensuring accurate product recognition and real-time inventory updates. This precise monitoring capability enables the system to identify discrepancies and potential theft attempts, thereby significantly improving inventory accuracy and security.
Mr. Gadi Graus, CEO of A2Z, commented, “A2Z focuses on leveraging artificial intelligence to provide sophisticated solutions for retail challenges. The patent-pending Shopping Cart Inventory Change Indicator System exemplifies this approach, offering an advanced method for inventory management and theft mitigation. As the retail sector evolves, Cust2Mate is committed to developing technologies that enhance operational efficiency and security.”
Rumours Swirl About Agape ATP’s Big Move – Is ATP2 Making a ComeWord on the street is that Agape ATP Corporation (NASDAQ: ATPC) might be gearing up for a major play. According to hearsay from one of the investors, Agape Superior Living, a subsidiary of ATPC, could be bringing back its flagship product, ATP2, as soon as mid to late this month.
If the whispers are true, this could mean big things for the company.
For those who’ve been following, the ATP Zeta Health Program which includes eight health and wellness products, there is a solid track record.
The program hit a massive RM18 million in monthly sales in March 2018 and totalled RM62 million for the year. ATP2, in particular, has always been the star of the show, loved for its health benefits with strong customer loyalty.
Should this relaunch happen, it could reignite serious consumer interest. After all, wellness products are in huge demand right now. Agape Superior Living might just be timing this perfectly to ride the wave of the health trend. If they pull this off, we could see some big numbers in terms of sales, which would be a win for the company and its investors.
For those watching ATPC’s stock, this could be a golden opportunity. The company’s products have a history of doing well, and if ATP2’s relaunch sparks the same kind of sales it did before the pandemic, it could signal a new growth phase for Agape Superior Living. Investors are keeping a close eye on this, and some are saying this could be the beginning of something big.
So, while nothing official has been confirmed just yet, if you’re an investor in ATPC or thinking about jumping in, you might want to watch what happens over the next few weeks. ATP2’s potential comeback could be the catalyst for renewed growth and profitability in the health and wellness space.
Stay tuned. If the rumours are true, we could be looking at some exciting times ahead for Agape ATP Corporation.
NASDAQ:ATPC